LYTGOBI cpr pellic 4 mg 28 pce
7680697140024
CH-69714
L01EN04
07.16.1.
1 / 3
google
Details
- Product number
- 6971401
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- futibatinibum 4 mg, natrii laurilsulfas corresp. natrium 0.3196 mg, lactosum monohydricum 5.4 mg, maydis amylum, hydroxypropylcellulosum, mannitolum 43.6 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, aqua purificata, Überzug: hypromellosum, macrogolum 6000, E 171, aqua purificata, magnesii stearas, pro compresso obducto.
Articles (1)
Lytgobi 4 mg, Filmtabletten
Filmtabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.3196 MG | Substance | HBESI |
|
(N/A)
|
5.4 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
43.6 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Taiho Oncology Europe GmbH
6340 Baar
Authorization information
- Swissmedic authorization number
- 69714
- Drug name
- Lytgobi, Filmtabletten
- Galenic form
- FILM
- ATC Code
- L01EN04
- Authorization status
- B
- Dispensation category
- A
- First authorization
- 08/10/2024
- Authorization expiration date
- 08/10/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LYTGOBI cpr pellic 4 mg 28 pce
- Description (DE)
- LYTGOBI Filmtabl 4 mg 28 Stk
- Market launch
- 31/12/2028
- Narcotic (BTM)
- No